CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Drug Reimbursement Recommendation - Botox

Published on: October 22, 2019
Result type: News

Today, CADTH has issued final recommendations for:

onabotulinumtoxinA (Botox)

Indications: Migraine, chronic
Recommendation: Reimburse with clinical criteria and/or conditions

For more information